Chromosome Microarray (CMA) Detection (3) - CapitalBio Technology Co., Ltd.

Testing Content

Detection of 23 pairs of chromosomal aneuploidy and whole genome chromosomal abnormalities greater than 100kb.

Testing Method

Sample Requirements

Venous Blood: Collect 4mL, store at 2-8°C. Transport with biological ice packs (2-8°C) within 72 hours. Use an EDTA anticoagulant tube.

Reporting Cycle

10 working days

Clinical Application Overview

Assess chromosomal abnormalities and investigate the genetic causes of recurrent miscarriage and infertility.

PREV: Chromosome Microarray (CMA) Detection 2.0 (4)

NEXT: Chromosome Microarray (CMA) Detection

Related IVD Products

Related News Of IVD Technology

Unveiling the Microbial World: The Power of Whole Genome Shotgun MetagenomicsJune 5, 2024Whole genome shotgun metagenomics is a revolutionary technique that allows scientists to sequence the genomes of entire microbial communities without the need for culturing them first. This groundbrea...view
From Data to Discovery: How Microarray Scanners Drive Breakthroughs in Molecular BiologyJanuary 4, 2024In the world of molecular biology, technological advancements are constantly driving new discoveries and pushing the boundaries of scientific knowledge. One such breakthrough technology is the microar...view
Knowledge About Transcriptome SequencingDecember 1, 2022In a broad sense, the transcriptome refers to the collection of all transcripts in a cell under a certain physiological condition, including messenger RNA, ribosomal RNA, transfer RNA and non-coding R...view
What Is the Application of Bacterial Genome Sequencing?November 10, 2023Bacterial genome sequencing has become an essential part of modern biology and medicine. This advanced technology allows scientists to decipher the complete set of genes in a bacterial cell, revealing...view
Applications and Innovations of Microfluidic Platforms in Drug AnalysisNovember 13, 2024The prospects of microfluidic platforms in drug analysis applicationsThe pharmaceutical development field is now facing increasingly powerful research and development barriers and steep patent cliffs,...view
CapitalBio: Revolutionizing Genomics with Advanced Microarray ScannersFebruary 7, 2024Introduction to CapitalBio and Microarray TechnologyCapitalBio, a global leader in biotechnology, is revolutionizing the field of genomics with its advanced microarray scanners. These instruments, inc...view